|
|
|
April 7, 2010 ALDA
receives FDA permission to sell products in the US Vancouver, BC - ALDA Pharmaceuticals
Corp. (APH:TSX-V, APCSF:OTCBB, "ALDA") is pleased to announce
that a “NDC” (National Drug Code) Labeller Code has been assigned to the
Company by the US Food
and Drug Administration (“FDA”). The NDC number allows the Company to sell
OTC monograph products in the US. Dr.
Terrance Owen, President & CEO, states, "Receiving the NDC number from
the FDA provides ALDA with the consent that is needed to introduce our products
in the US. This is the first step in fulfilling our strategy of securing foreign
sales for current products while we continue to pursue the testing
and registration of the T36® therapeutics”.
About ALDA Pharmaceuticals Corp. ALDA is focused on the development of
infection-control therapeutics derived from its patented T36®
technology.
The company trades on the TSX Venture Exchange under the symbol APH and on the OTCBB
under the symbol APCSF. The Company is the Official Supplier of the Vancouver
2010 Olympic
Winter Games, Vancouver 2010 Paralympic Winter Games, the Canadian Olympic
Committee, the 2010 Canadian Olympic Team and the 2012 Canadian
Olympic Team for antiseptic hand sanitizer, disinfectant and disinfectant cleaning
products. The Company has also been selected as one of the TSX Venture
50 companies in the Technology and Life Sciences sector for 2010. Terrance G. Owen, Ph.D., MBA President & CEO
ALDA Pharmaceuticals Corp.
www.aldacorp.com
Sales Management 604-521-8300 Diane
Mann, Account Executive
Extension 4
diane_mann@aldacorp.com Tracy
Haubrich, Account Manager
Extension
7
tracy_haubrich@aldacorp.com Steve
Cozine, Account Manager
Extension
6
steve_cozine@aldacorp.com Retail
Sales Shoppers Drug Mart, London Drugs,
T&T Supermarket, IGA Marketplace, Pharmasave Commercial Sales Acklands-Grainger Inc. ALDA
Pharmaceuticals Corp. 635 Columbia Street, New Westminster, BC V3M 1A7 Canada Telephone [604] 521.8300 - Facsimile [604] 521.8322 www.aldacorp.com
|